A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : DDAVP

Search Conditions:
Search Keyword : DDAVP
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: DDAVP
Appearance Frequency: 554 time(s)
Long forms: 21

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
1-desamino-8-D-arginine vasopressin
(530 times)
Hematology
(104 times)
AVP (85 times)
vWF (72 times)
vWd (49 times)
1974 Influence of glyburide on the antidiuretic response induced by 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
delivery of desmopressin acetate
(2 times)
Pharmacology
(2 times)
--- 1995 Effect of iontophoretic patterns on in vivo antidiuretic response to desmopressin acetate administered transdermally.
derivative desmopressin
(2 times)
Biochemistry
(1 time)
BT (1 time)
EGF (1 time)
1986 Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time.
desmopressin diacetate arginine vasopressin
(2 times)
Urology
(1 time)
--- 2002 Hyponatremia associated with desmopressin for the treatment of nocturnal polyuria.
double-blind cross-over trial of Desmopressin
(2 times)
Urology
(1 time)
--- 1982 The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female.
antifibrinolytics,1-deamino-8-D-arginine vasopressin
(1 time)
Allergy and Immunology
(1 time)
AHA (1 time)
APTT (1 time)
FVIII (1 time)
2011 Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options.
data are available regarding optimal treatment with desmopressin
(1 time)
Hematology
(1 time)
CFCs (1 time)
VWD (1 time)
2001 Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease.
data indicated that perioperative administration of the hemostatic peptide desmopressin
(1 time)
Neoplasms
(1 time)
--- 2010 Effects of the synthetic vasopressin analog desmopressin in a mouse model of colon cancer.
decreased RIPA and a poor response of VWF:RCo to desmopressin
(1 time)
Hematology
(1 time)
Ag (1 time)
CB (1 time)
FVIII (1 time)
2009 Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
10  defective, but varying, release of VWF into plasma after desmopressin
(1 time)
Genetics
(1 time)
AP-3 (1 time)
BLOC (1 time)
HPS (1 time)
2016 BLOC-2 subunit HPS6 deficiency affects the tubulation and secretion of von Willebrand factor from mouse endothelial cells.
11  deficiencies can be achieved by administering the synthetic peptide desmopressin
(1 time)
Hematology
(1 time)
AVWS (1 time)
FVIII (1 time)
VWD (1 time)
2008 The use of desmopressin in von Willebrand disease: the experience of the first 30 years (1977-2007).
12  dehydration test followed by the administration of synthetic arginine-vasopressin
(1 time)
Medicine
(1 time)
--- 1984 Antidiuretic function in Sheehan's syndrome.
13  deprivation, antidiuretic hormone
(1 time)
Medicine
(1 time)
GFR (1 time)
1981 The effect of fluid deprivation, antidiuretic hormone and forced fluid intake on 51-Cr-EDTA clearance.
14  desamino-D-arginine vasopressin, Minirin
(1 time)
Pediatrics
(1 time)
--- 1978 DDAVP in childhood nocturnal enuresis.
15  designed to evaluate the safety and efficacy of Desmopressin
(1 time)
Medicine
(1 time)
PNE (1 time)
1993 The efficacy of intranasal DDAVP therapy in children with nocturnal enuresis.
16  desmopressin-L-desamino-8-arginine-vasopressin
(1 time)
Physiology
(1 time)
AVP (1 time)
V2R (1 time)
2009 VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.
17  developed countries use standard therapy, employing desmopressin
(1 time)
Hematology
(1 time)
VWD (1 time)
vWF (1 time)
2011 Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder.
18  dissolving microneedles and administered percutaneously to rat skin: desmopressin
(1 time)
Pharmacology
(1 time)
BA (1 time)
FL (1 time)
GRN (1 time)
2012 Effect of lipophilicity on the bioavailability of drugs after percutaneous administration by dissolving microneedles.
19  diverse agents associated with functional stimulation/perturbation
(1 time)
Pathology
(1 time)
DA (1 time)
DIVI (1 time)
EC (1 time)
2014 Evaluation of von Willebrand factor and von Willebrand factor propeptide in models of vascular endothelial cell activation, perturbation, and/or injury.
20  drugs were: AVT, V1-agonist ((Phe2 Orn8)VT), and V2-agonist
(1 time)
Endocrinology
(1 time)
AVP (1 time)
AVT (1 time)
MAP (1 time)
1993 At low dose, arginine vasotocin has vasopressor rather than vasodepressor effect in chickens.
21  during surgery it was effectively treated with synthetic desmopressin
(1 time)
Endocrinology
(1 time)
DI (1 time)
2004 Endocrine function and water metabolism in children and adolescents with surgically treated intra/parasellar tumors.